ENTERA BIO LTD. Earnings Per Share, Basic and Diluted
ENTERA BIO LTD. (ENTX) reported Earnings Per Share, Basic and Diluted of $0.13 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-12
- ENTERA BIO LTD. earnings per share, basic and diluted for the quarter ending 2022-03-31 was $0.13, a 30.00% increase year-over-year.
- ENTERA BIO LTD. earnings per share, basic and diluted for the quarter ending 2021-03-31 was $0.10.
- ENTERA BIO LTD. earnings per share, basic and diluted for fiscal 2021 was $0.47, a 29.85% decline from fiscal 2020.
- ENTERA BIO LTD. earnings per share, basic and diluted for fiscal 2020 was $0.67.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|
| 2022-03-31 | $0.13 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $0.47 10-K · filed 2022-03-08 | |
| 2021-03-31 | $0.10 10-Q · filed 2022-05-12 | |
| 2020-12-31 | $0.67 10-K · filed 2022-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |